![coronavirus]()
A Yale medical doctor and professor of epidemiology penned a
frustrated op-ed in Newsweek, wanting to know why “tens of thousands of patients
with COVID-19 are dying unnecessarily.” The solution, Harvey A. Risch says,
already exists: Hydroxychloroquine works when it’s given very early in the
infection, “especially when given in combination with the antibiotics
azithromycin or doxycycline and the nutritional supplement zinc.”
COVID-19 deaths plummeted in northern Brazil when doctors
began treating patients with azithromycin and hydroxychloroquine. In contrast,
when Sweden banned use of hydroxychloroquine, deaths increased fourfold, and remained
so. Other examples abound.
At least seven studies support this treatment, and it’s very
inexpensive. “So why aren’t health providers across the U.S. using this
highly-effective, cost-efficient medicine? Risch asks. “For the sake of
high-risk patients, for the sake of our parents and grandparents, for the sake
of the unemployed, for our economy and for our polity, especially those
disproportionally affected, we must start treating immediately.”
SOURCE: Newsweek
July 23, 2020